GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl peptidase-4 inhibitors, according to findings scheduled for presentation at ASCO Annual Meeting
Erectile dysfunction ED is estimated to affect around 20% of adult males over the age of 20, and by 2025, it is projected to impact 322 million men globally
#GLP1 #Semaglutide #MetabolicHealth #LongevityMedicine #Ozempic #WhitePineMedical #CanadianHealthcare #PreventiveMedicine #PhysicianLeadership James French, MD Founder, White Pine Medical | Emergency Physician White Pine Medical is building the metabolic assessment infrastructure Canada's GLP-1 population needs.
These supplements are often touted as natural alternatives, but it is important to look at the actual data
The Lipo-C Skinny Shot can help enhance your metabolic rate, making it easier for your body to burn calories efficiently
When taking medications that slow digestion, adequate fiber intake becomes even more important